ISFP2024 (The 8th World Congress of the International Society for Fertility Preservation) ISFP2024 (The 8th World Congress of the International Society for Fertility Preservation)

View the presenters' abstracts on the Online Abstract page.
A password is required and will be sent separately to registered participants only.

Timetable

Program

Special Lecture

8:00 - 8:40, Sunday, November 17
Room 1
(Hall, 4F, JP Tower Hall & Conference)

Honorary Lecture 1

8:00 - 9:00, Saturday, November 16
Room 1
(Hall, 4F, JP Tower Hall & Conference)

Honorary Lecture 2

8:00 - 9:00, Saturday, November 16
Room 1
(Hall, 4F, JP Tower Hall & Conference)

President's Lecture

8:00 - 9:00, Saturday, November 16
Room 1
(Hall, 4F, JP Tower Hall & Conference)

Session

Session 1
ASFP Session with ISFP: Case Discussion

9:20 - 11:00, Friday, November 15
Room 1
(Hall, 4F, JP Tower Hall & Conference)

Session 2
IVM

9:20 - 11:10, Friday, November 15
Room 2
(Conference Room B, 5F, JP Tower Hall & Conference)

Session 3
Ovarian Tissue Transportation

11:20 - 12:40, Friday, November 15
Room 1
(Hall, 4F, JP Tower Hall & Conference)

Session 4
KSFP Session

11:20 - 12:40, Friday, November 15
Room 2
(Conference Room B, 5F, JP Tower Hall & Conference)
Single-cell RNA Sequencing Reveals the Cell-Type-Specific Mechanisms of Ovarian Regeneration in Rat POI Models Treated with Platelet-Rich Plasma (PRP)
Long-term outcomes of fertility preservation counselling in women of reproductive age with cancer
Effect of autologous bone marrow derived stem cells and platelet rich plasma therapy after hysteroscopy for severe Asherman’s syndrome
Development and alpha testing of decision aid for decision-making of fertility preservation considering cancer patient’s personal values
Effect of Long-term Humanin Treatment on Preventing Age-Related Decline in Oocyte Quality

Session 5
PGT

14:10 - 15:10, Friday, November 15
Room 2
(Conference Room B, 5F, JP Tower Hall & Conference)

Session 6
Ovarian Tissue Transplantaion

15:20 - 16:40, Friday, November 15
Room 1
(Hall, 4F, JP Tower Hall & Conference)

Session 7
CSFP Session

15:20 - 16:40, Friday, November 15
Room 2
(Conference Room B, 5F, JP Tower Hall & Conference)
Considerations and thoughts of patients undergoing medical fertility preservation--a new perspective on promoting fertility preservation
Clinical Outcomes of Intracytoplasmic Sperm Injection with Fresh or Cryopreserved Ejaculated or Surgically Retrieved Sperm
Research of Application and Mechanism of Hyperbaric Oxygen Therapy on Ovarian Tissue Transplantation
Fertility Preservation in Young Breast Cancer Patients: A National Survey on Knowledge, Attitudes, and Practices among Breast Surgical Healthcare Providers in China

Session 8
Ovarian Protection

17:00 - 18:00, Friday, November 15
Room 1
(Hall, 4F, JP Tower Hall & Conference)
Activation or Apoptosis: Combined suppression of intrinsic and extrinsic follicle activation pathways completely prevents cyclophosphamide-induced follicle loss, while DNA damage does not end in oocyte apoptosis
Estimating the effectiveness of GnRHa drugs for ovarian protection during cancer treatment through a RCT including adolescents and adults – Why such a study is needed

Session 9
Oral Session 1

17:00 - 18:20, Friday, November 15
Room 2
(Conference Room B, 5F, JP Tower Hall & Conference)
Progress in Ovarian Tissue Cryopreservation at the Fertility Preservation Center of Obstetrics and Gynecology Hospital of Fudan University
An Update of Graft Function and Reproductive Outcomes from Ovarian Tissue Cryopreservation and Graft: Lessons from 46 Women
ELUCIDATING KI-67, CASPASE-3 AND HEMATOXYLIN & EOSIN (H&E) IN ASSESSING THE INTEGRITY OF OVARIAN FOLLICLE FOLLOWING OVARIAN TISSUE CRYOPRESERVATION VIA VITRIFICATION METHOD AMONG ONCOFERTILITY PATIENT IN UNIVERSITY HOSPITAL SETTING
Insights into how freezing affects follicle development in Human Ovarian Tissues
Mechanism of mitochondrial targeted antioxidant MitoQ promoting angiogenesis after frozen-thawed ovarian tissue transplantation
Nano-curcumin Potentially Ameliorates Hormonal Function and Follicular Counts Following the
Vitrification and Transplantation of Rats Ovarian Tissue
Exploring the mechanism of Everolimus in inhibiting the activation of primordial follicles to improve the efficiency of human ovarian cortex cryopreservation and resuscitation-transplantation
CORRELATIONS BETWEEN HISTOLOGY TYPE AND FIGO STAGE OVARIAN MALIGNANCY WITH TYPE OF SURGERY IN ADOLESCENCE AND YOUNG ADULT PATIENT

Session 10
New Technology 1

9:10 - 10:30, Saturday, November 16
Room 1
(Hall, 4F, JP Tower Hall & Conference)

Session 11
Benign Disease 1: Gynecological Conditions and Uterus

9:10 - 10:30, Saturday, November 16
Room 2
(Conference Room B, 5F, JP Tower Hall & Conference)

Session 12
JSFP Session

10:50 - 12:10, Saturday, November 16
Room 1
(Hall, 4F, JP Tower Hall & Conference)

Session 13
Nurse Session

10:50 - 12:10, Saturday, November 16
Room 2
(Conference Room B, 5F, JP Tower Hall & Conference)

Session 14
Clinical Practice

14:00 - 15:50, Saturday, November 16
Room 1
(Hall, 4F, JP Tower Hall & Conference)

Session 15
Oral Session 2: Best Oral Presentation Finalists

Best Oral Presentation Award Winner
13:40 - 15:40, Saturday, November 16
Room 2
(Conference Room B, 5F, JP Tower Hall & Conference)
Melatonin protects intact rat ovarian transplantation via the MT1/Nrf2/ARE pathway
Oocyte cryopreservation in peripubertal girls with Turner’s syndrome: An Analysis of Molecular and Clinical Reproductive Parameters
Beyond the Cancer: Twenty-Year Analysis of Fertility Preservation Outcomes in Young Women with Cancer
Ovarian tissue cryopreservation in France: data from the GRECOT (Research and study group for ovarian and testicular cryopreservation)
Australian Experience with a National Ovarian and Testicular tissue Transport and Cryopreservation Service (NOTTCS)
Inflammatory Signaling is Activated Downstream of Cyclophosphamide Exposure and is Sufficient to Induce Damage to Mouse Ovarian Reserve
AMHR2BP for the prevention of cyclophosphamide (CX)-induced ovarian follicle depletion in mice
Fertility Preservation and Live Birth Using a Gelatin-Methacryloyl-based Bioprosthetic Ovary Mimicking Natural Ovarian Function
Ovarian Tissue after Thawing: Metabolic Recovery and Hormonal Effects in Angiogenesis
THE FIRST COMPARATIVE STUDY ON THE EFFECTIVENESS OF SLOW FREEZING AND VITRIFICATION OF HUMAN OVARIAN TISSUE BY XENOTRANSPLANTATION MODEL IN VIETNAM

Session 16
Oral Session 3

16:00 - 17:20, Saturday, November 16
Room 1
(Hall, 4F, JP Tower Hall & Conference)
Transplantation of cryopreserved ovarian tissue in two patients of gyneacologic cancers
Fertility Rescuing by Heathy Ovarian Tissue Graft in Mouse Model of Chemotherapy-Induced Ovarian Insufficiency
A study of the delivery course in cases of maternal deaths from malignant tumors in Japan
Associations Between Nutrient Intake and Menopausal Age in Korean Women: Findings from the Korea National Health and Nutrition Examination Survey
Evaluating mitochondrial DNA Copy Number for Predicting IVF Outcomes in Euploid Blastocysts
The relationship between nutritional status, DNA damage and metabolites in women with infertility in Malaysia
Macrophage Infiltration and Fibrosis of the Ovaries in Chemotherapy-Induced Ovarian Insufficiency

Session 17
Oral Session 4

16:00 - 17:20, Saturday, November 16
Room 2
(Conference Room B, 5F, JP Tower Hall & Conference)
Letrozole-induced ovulation for endometrial preparation in frozen embryo transfer cycles for women with endometrial intraepithelial neoplasia or cancer
IVM on the Patients required Emergent Oocyte Retrieval for Fertility Preservation
Focusing on Time-Lag Post-In Vitro Maturation in Oocyte Tissue Cryopreservation: A Laboratory Perspective
Effects of Prolonged Cryopreservation of Oocytes on Fertilization and Pregnancy Outcomes: A Systematic Review and Meta-Analysis
Assessing oncological safety and fertility potential in ovarian cortex surrounding epithelial and early-stage malignant ovarian tumors inpatients of reproductive age
The oncologic and reproductive outcomes after fertility-sparing surgery in gynecological cancers
Knowledge, Attitude, and Practice Toward Fertility Preservation Among Young Women with Systemic Autoimmune Rheumatic Disease Facing Treatment with Gonadotoxic Agents in Indonesia :A Cross-sectional Study
PREGNANCY OUTCOMES FOLLOWING FERTILITY PRESERVATION UTILIZING IN VITRO MATURATION OF OOCYTES IN CANCER PATIENTS: A SYSTEMATIC REVIEW

Session 18
Artificial Ovary

9:00 - 10:20, Sunday, November 17
Room 1
(Hall, 4F, JP Tower Hall & Conference)

Session 19
ASFP Session: Fertility Preservation in Developing Countries

9:00 - 10:20, Sunday, November 17
Room 2
(Conference Room B, 5F, JP Tower Hall & Conference)

Session 20
Testicular Tissue Cryopreservation

10:30 - 11:30, Sunday, November 17
Room 1
(Hall, 4F, JP Tower Hall & Conference)

Session 21
Benign Disease 2: Turner Syndrome

10:30 - 11:30, Sunday, November 17
Room 2
(Conference Room B, 5F, JP Tower Hall & Conference)

Session 22
Oral Session 5

13:00 - 14:00, Sunday, November 17
Room 1
(Hall, 4F, JP Tower Hall & Conference)

Session 23
Oral Session 6

13:00 - 14:00, Sunday, November 17
Room 2
(Conference Room B, 5F, JP Tower Hall & Conference)
Cell-based Menopausal Hormone Therapy using Injectable Biomimetic Artificial Ovary with Lower Breast Cancer Risk
The step by step video presentation and analysis of the single-port laparoscopic partial ovariectomy for Ovarian Tissue Cryopreservation
Application of pump-free microfluidic system utilizing hydrostatic pressure on human cumulus cell culture: A model for long-term in vitro follicle growth
The Significance of Genetic Counseling in Fertility Preservation for Cancer Patients
Long term safety of controlled ovarian stimulation for fertility preservation prior to chemotherapy treatment in breast cancer patients

Session 24
Ovarian Tissue Cryopreservation

14:10 - 15:30, Sunday, November 17
Room 1
(Hall, 4F, JP Tower Hall & Conference)

Session 25
New Technology 2

14:10 - 15:30, Sunday, November 17
Room 2
(Conference Room B, 5F, JP Tower Hall & Conference)

Afternoon Seminar
Blood Cancer

14:10 - 15:10, Friday, November 15
Room 1
(Hall, 4F, JP Tower Hall & Conference)
Preservation of fertility in patients with hematological malignancies
Safe and successful ovarian transplantations post LEUKEMIA after combined various MRD excluding tests
Future novel options for contaminated tissue
Chugai Pharmaceutical Co., Ltd.

Luncheon Seminar 1
Improving Ovarian Transplantation and In Vitro Primordial Follicle Growth Outcomes with Cryopreserved Tissue

Luncheon Seminar 2
Introduction to CAP Reproduction Laboratory Accreditation Program

13:00 - 14:00, Friday, November 15
Room 2
(Conference Room B, 5F, JP Tower Hall & Conference)
Introduction to CAP Reproduction Laboratory Accreditation Program
CGI, K.K.

Luncheon Seminar 3
Cancer Survivorship

12:30 - 13:50, Saturday, November 16
Room 1
(Hall, 4F, JP Tower Hall & Conference)
Fertility issues in cancer patients and survivors - from an oncologist’s perspective
Fertility preservation and infertility treatment in women with very low ovarian reserve
Merck

Luncheon Seminar 4
When It Comes to Fertility Preservation and Reproductive Genetics, What Is Best Practice for Patients?

12:30 - 13:30, Saturday, November 16
Room 2
(Conference Room B, 5F, JP Tower Hall & Conference)
Incorporating reproductive genetics into IVF: Carrier screening, PGT-M and PGT-A
Fertility preservation, oocyte vitrification and ovarian tissue cryopreservation
Vitrolife, Igenomix

Luncheon Seminar 5
Ovarian Tissue Cryopreservation -Bench to Bedside

11:50 - 12:50, Sunday, November 17
Room 1
(Hall, 4F, JP Tower Hall & Conference)
Technological Development for Fertility Preservation
Ovarian tissue cryopreservation: Bench-to-Bedside
- From an oncological perspective: Practice in pediatric patients -
Ovarian tissue cryopreservation from the reproductive medicine side
IVF JAPAN

Luncheon Seminar 6
Breast Cancer

11:50 - 12:50, Sunday, November 17
Room 2
(Conference Room B, 5F, JP Tower Hall & Conference)